Press Releases

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
Library
Events
Press Releases

Get PharmaVoice in your inbox

The free newsletter covering the top industry headlines

Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

PURE Engagement Announces 2025 Patient Support Program Award Winners Across Major Therapeutic Areas

Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions

Brick City Greenhouse Celebrates 10 Years of Redefining the Healthcare Marketing Agency Model for Startups

Receptor.AI Partners with Oragenics to Accelerate AI-Guided Discovery of Neurological Therapeutics

PumasAI Named Best Clinical Pharmacology Tech Innovator 2025 by Global Health and Pharma for the Second Year in a Row

OpenEvidence and Veeva Announce Open Vista Partnership

Gifthealth is First to Serve 6m Patients Via Direct-to-Patient Platform

Veeva AI Agents to Be Released Across All Veeva Applications

Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030

VDX.tv Partners with PurpleLab

BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial of ML-016 in Advanced Cancers with Lung and/or Liver Involvement

Global Medical Device Leader Stefan Bohling Joins Shaily

Where Innovation and Vision Drive Progress - ACI's Inaugural West Coast WILS Summit

Nazaré Launches Access Academy, a Training Solution to Help Navigate the Complexities of Patient Access in the US

Wiley Launches Wiley Focus to Expand into Corporate Markets

Medable Launches The Industry’s First Agentic AI Platform and CRA Agent; Removes Bottlenecks in Clinical Development

Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform

TRUE RX HEALTH STRATEGISTS LAUNCHES NEW MOBILE APP, True Rx+™

TrialAssure’s Zach Weingarden Joins Other Pharmaceutical Industry Leaders to Present on the Future of AI in Drug Development at RAPS Convergence 2025

TransCelerate and FDA Collaborate to Advance Use of Pragmatic Elements in Clinical Trials

Reach our audience

Don't miss the most important voices in pharma